{
    "nctId": "NCT02679040",
    "briefTitle": "Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and Radiotherapy",
    "officialTitle": "Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and Radiotherapy",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 101,
    "primaryOutcomeMeasure": "Rate of histological response of an infiltrating tumor within various molecular subgroups",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \\> 18 years,\n* Infiltrating carcinoma,\n* Neoadjuvant chemotherapy indication,\n* Radiotherapy indication,\n* 0 or 1 score Performance status (WHO),\n* Signed informed consent,\n* Affiliation to Social Security System\n\nExclusion Criteria:\n\n* Lobular carcinoma,\n* \"Luminal A\" Tumor (RH+ and Her2 negative with grade I, and tumor RH+ Her2 negative with grade II and with Ki67\\<20%),\n* Attempt of first conservative treatment,\n* Metastatic breast cancer,\n* Inflammatory carcinoma,\n* History of homolateral or controlateral mammary carcinoma,\n* Progression disease (despite neoadjuvant chemotherapy),\n* Contraindications in an immediate mammary reconstruction by scrap of big dorsal (comorbidity),\n* Any psychological, familial, sociological or geographical condition-potentially hampering compliance with the study protocol or follow-up schedule,\n* Patients deprived of liberty or placed under the authority of a tutor.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}